Loading grant details…
Active
CAREERS
Swiss National Science Foundation
Randomized evaluation of the routine use of circulating tumor DNA in patients with advanced malignancies using routinely collected patient outcome data
$19.3M
CHF
| Funder | Swiss National Science Foundation |
|---|---|
| Recipient Organization | University of Basel – Bs |
| Country | Switzerland |
| Start Date | Sep 01, 2024 |
| End Date | Aug 31, 2027 |
| Duration | 1,094 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swiss National Science Foundation |
| Grant ID | 323530_229969 |
Grant Description
liquid biopsy
All Grantees
University of Basel – Bs
Advertisement
Advertisement
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Start Year
2024
End Year
2027
Grantees
1
Related Grants
Three-terminal particle-exchange heat engines for efficient...
Swiss National Science Foundation
$195.86M CHF
Does food democracy matter? Linking the deliberative quality...
Swiss National Science Foundation
$192.33M CHF
Carceral space and circulations: a transnational and regiona...
Swiss National Science Foundation
$188.61M CHF
Advertisement
